Skip to main content
. 2023;26(11):1342–1349. doi: 10.22038/IJBMS.2023.71522.15548

Figure 1.

Mitochondrial calcium uniporter (MCU) expression correlates with the prognosis of BC patients

Figure 1

The effect of MCU expression on the survival data of breast cancer (BC) patients was examined using the Kaplan-Meier plotter for BC. (A) Overexpression of MCU was associated with lower overall survival (OS) of BC patients. (B) Overexpression of MCU was associated with lower distant metastasis-free survival (DMFS) in BC patients. (C) Expression of MCU was not correlated with post-progression survival (PPS). (D) Overexpression of MCU was associated with lower relapse-free survival (RFS) in BC patients